216 related articles for article (PubMed ID: 32532990)
1. Quantification of ongoing APOBEC3A activity in tumor cells by monitoring RNA editing at hotspots.
Jalili P; Bowen D; Langenbucher A; Park S; Aguirre K; Corcoran RB; Fleischman AG; Lawrence MS; Zou L; Buisson R
Nat Commun; 2020 Jun; 11(1):2971. PubMed ID: 32532990
[TBL] [Abstract][Full Text] [Related]
2. Cytidine Deaminase APOBEC3A Regulates PD-L1 Expression in Cancer Cells in a JNK/c-JUN-Dependent Manner.
Zhao K; Zhang Q; Flanagan SA; Lang X; Jiang L; Parsels LA; Parsels JD; Zou W; Lawrence TS; Buisson R; Green MD; Morgan MA
Mol Cancer Res; 2021 Sep; 19(9):1571-1582. PubMed ID: 34045311
[TBL] [Abstract][Full Text] [Related]
3. APOBEC3A and APOBEC3B Activities Render Cancer Cells Susceptible to ATR Inhibition.
Buisson R; Lawrence MS; Benes CH; Zou L
Cancer Res; 2017 Sep; 77(17):4567-4578. PubMed ID: 28698210
[TBL] [Abstract][Full Text] [Related]
4. Transient overexpression of exogenous APOBEC3A causes C-to-U RNA editing of thousands of genes.
Sharma S; Patnaik SK; Kemer Z; Baysal BE
RNA Biol; 2017 May; 14(5):603-610. PubMed ID: 27149507
[TBL] [Abstract][Full Text] [Related]
5. APOBEC3A cytidine deaminase induces RNA editing in monocytes and macrophages.
Sharma S; Patnaik SK; Taggart RT; Kannisto ED; Enriquez SM; Gollnick P; Baysal BE
Nat Commun; 2015 Apr; 6():6881. PubMed ID: 25898173
[TBL] [Abstract][Full Text] [Related]
6. Creating RNA Specific C-to-U Editase from APOBEC3A by Separation of Its Activities on DNA and RNA Substrates.
Tang G; Xie B; Hong X; Qin H; Wang J; Huang H; Hao P; Li X
ACS Synth Biol; 2021 May; 10(5):1106-1115. PubMed ID: 33938211
[TBL] [Abstract][Full Text] [Related]
7. APOBEC3A is a prominent cytidine deaminase in breast cancer.
Cortez LM; Brown AL; Dennis MA; Collins CD; Brown AJ; Mitchell D; Mertz TM; Roberts SA
PLoS Genet; 2019 Dec; 15(12):e1008545. PubMed ID: 31841499
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive Analyses Identify APOBEC3A as a Genomic Instability-Associated Immune Prognostic Biomarker in Ovarian Cancer.
Xu F; Liu T; Zhou Z; Zou C; Xu S
Front Immunol; 2021; 12():749369. PubMed ID: 34745121
[TBL] [Abstract][Full Text] [Related]
9. Genotoxic stress and viral infection induce transient expression of APOBEC3A and pro-inflammatory genes through two distinct pathways.
Oh S; Bournique E; Bowen D; Jalili P; Sanchez A; Ward I; Dananberg A; Manjunath L; Tran GP; Semler BL; Maciejowski J; Seldin M; Buisson R
Nat Commun; 2021 Aug; 12(1):4917. PubMed ID: 34389714
[TBL] [Abstract][Full Text] [Related]
10. Monitoring APOBEC3A protein levels in human cancer cells.
Dananberg A; Maciejowski J
Methods Cell Biol; 2024; 182():313-327. PubMed ID: 38359985
[TBL] [Abstract][Full Text] [Related]
11. Correlation of gene expression and associated mutation profiles of APOBEC3A, APOBEC3B, REV1, UNG, and FHIT with chemosensitivity of cancer cell lines to drug treatment.
Vural S; Simon R; Krushkal J
Hum Genomics; 2018 Apr; 12(1):20. PubMed ID: 29642934
[TBL] [Abstract][Full Text] [Related]
12. APOBEC3A is implicated in a novel class of G-to-A mRNA editing in WT1 transcripts.
Niavarani A; Currie E; Reyal Y; Anjos-Afonso F; Horswell S; Griessinger E; Luis Sardina J; Bonnet D
PLoS One; 2015; 10(3):e0120089. PubMed ID: 25807502
[TBL] [Abstract][Full Text] [Related]
13. Roles of APOBEC3A and APOBEC3B in Human Papillomavirus Infection and Disease Progression.
Warren CJ; Westrich JA; Doorslaer KV; Pyeon D
Viruses; 2017 Aug; 9(8):. PubMed ID: 28825669
[TBL] [Abstract][Full Text] [Related]
14. Unraveling the Enzyme-Substrate Properties for APOBEC3A-Mediated RNA Editing.
Kim K; Shi AB; Kelley K; Chen XS
J Mol Biol; 2023 Sep; 435(17):168198. PubMed ID: 37442413
[TBL] [Abstract][Full Text] [Related]
15. RNA editing enzyme APOBEC3A promotes pro-inflammatory M1 macrophage polarization.
Alqassim EY; Sharma S; Khan ANMNH; Emmons TR; Cortes Gomez E; Alahmari A; Singel KL; Mark J; Davidson BA; Robert McGray AJ; Liu Q; Lichty BD; Moysich KB; Wang J; Odunsi K; Segal BH; Baysal BE
Commun Biol; 2021 Jan; 4(1):102. PubMed ID: 33483601
[TBL] [Abstract][Full Text] [Related]
16. APOBEC3A/B-induced mutagenesis is responsible for 20% of heritable mutations in the TpCpW context.
Seplyarskiy VB; Andrianova MA; Bazykin GA
Genome Res; 2017 Feb; 27(2):175-184. PubMed ID: 27940951
[TBL] [Abstract][Full Text] [Related]
17. Biochemical analysis of hypermutation by the deoxycytidine deaminase APOBEC3A.
Love RP; Xu H; Chelico L
J Biol Chem; 2012 Aug; 287(36):30812-22. PubMed ID: 22822074
[TBL] [Abstract][Full Text] [Related]
18. Programmable C-to-U RNA editing using the human APOBEC3A deaminase.
Huang X; Lv J; Li Y; Mao S; Li Z; Jing Z; Sun Y; Zhang X; Shen S; Wang X; Di M; Ge J; Huang X; Zuo E; Chi T
EMBO J; 2020 Nov; 39(22):e104741. PubMed ID: 33058229
[TBL] [Abstract][Full Text] [Related]
19. Frame-shifted APOBEC3A encodes two alternative proapoptotic proteins that target the mitochondrial network.
Caval V; Suspène R; Khalfi P; Gaillard J; Caignard G; Vitour D; Roingeard P; Vartanian JP; Wain-Hobson S
J Biol Chem; 2021 Sep; 297(3):101081. PubMed ID: 34403699
[TBL] [Abstract][Full Text] [Related]
20. Mitochondrial double-stranded RNA triggers induction of the antiviral DNA deaminase APOBEC3A and nuclear DNA damage.
Wick C; Moghadasi SA; Becker JT; Fanunza E; Oh S; Bournique E; Buisson R; Harris RS
J Biol Chem; 2023 Sep; 299(9):105073. PubMed ID: 37474103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
